We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pill for Better Diagnosis of Breast Cancer

Video   Jul 11, 2018 | Original video from Michigan Engineering

 

Researchers from the University of Michigan have developed a diagnostic imaging pill enabling the early and more accurate diagnosis of cancerous tumors in breast tissue.

The pill contains a targeting molecule attached to a near-infrared fluorophore that, when absorbed into the bloodstream, will target cancerous tumor cells in breast tissue. A doctor could then use desktop fluorescent imaging equipment to see if any of the targeting molecules bound to any cells in the breast. This new screening method would be cheaper and more effective than current approaches.

The research was conducted in the lab of Greg Thurber, an assistant professor of chemical engineering, and was led by Sumit Bhatnagar, a PhD student in chemical engineering. The project was a collaboration between the College of Engineering and the College of Pharmacy. Kirti Verma, Yongjun Hu, Eshita Khera, Aaron Priluck and David Smith also contributed to the work.

 
More Information
 
 
 

Recommended Videos

Harnessing the Power of Immunology to Heal Ourselves

Video

How does our immune system work and how can it be manipulated to to develop new ways of healing our bodies?

WATCH NOW

Cell Fates - Division, Senescence and Death

Video

In this video, learn about the fates of a cell.

WATCH NOW

A "Living Drug" That Could Change the Way We Treat Cancer

Video

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE